Inibizione della chinesina mitotica 5 (Eg5/KIF11/HKSP) come bersaglio per lo sviluppo di farmaci anti tumorali per carcinomi squamosi del distretto cervico-facciale.
cun id:
279
CHEMIOTERAPIA
Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application.
Identification and Development of Tyrosyl DNA Phosphodiesterase Inhibitors for the Treatment of Lung Cancer
"Proteinfection", a novel strategy for intracellular protein delivery.
Trattamento chirurgico e/o locoregionale vs terapia sistemica in pazienti oligometastatici affetti da metastasi epatiche da carcinoma non del colon-retto ne neuroendocrino (NCRNNLM).
HDACs inhibitors as radiosensitizers for rhabdomyocarcoma cancer therapy
"Derivati monosostituiti del NIRAPARIB: effetti su colture cellulari ottenute da neoplasie umane".
ROLE OF CIRCULATING TUMOR CELLS (CTC) IN THE PREDICTION OF SURVIVAL AND RESPONSE TO TREATMENT IN PATIENTS WITH INTERMEDIATE AND ADVANCED HEPATOCELLULAR CARCINOMA (HCC).
Evaluation of the prognostic role of inflammatory markers in uterine cervical cancer: retrospective analysis.
Non invasive monitoring of aggressive lymphomas by next generation sequencing/droplet digital PCR on circulating tumor-DNA (ct-DNA)